Elanco’s Future, Lilly Investing in Insulin
Lilly is doubling down on diabetes. Manufacturing President Maria Crowe talks about plans for a $72 million investment in Indianapolis and weighs-in on what the future holds for animal health unit Elanco.
Get the best of Indiana business news. ONLY $1/week Subscribe Now
One Subscription, Unlimited Access to IBJ and Inside INdiana Business Subscribe Now
One Subscription, Unlimited Access to IBJ and Inside INdiana Business Upgrade Now
One Subscription, Unlmited Access to IBJ and Inside INdiana Business Upgrade Now